open access

Vol 9, No 3-4 (2008): Practical Diabetology
Review articles (submitted)
Published online: 2008-07-04
Get Citation

Hyperhomocysteinemia in type 2 diabetic patients - still is considered as a risk factor or it’s only marker of atherosclerosis?

Magdalena Borowska, Agata Adamczuk, Hanna Winiarska, Marzena Dworacka
Diabetologia Praktyczna 2008;9(3-4):182-186.

open access

Vol 9, No 3-4 (2008): Practical Diabetology
Review articles (submitted)
Published online: 2008-07-04

Abstract

Hyperhomocysteinemia is a pathological phenomenon markedly associated with atherosclerosis and atherosclerosis-related diseases development. Patients with diabetes type 2 are especially affected by hiperhomocysteinemia. However, there is quite a lot of doubts if hiperhomocysteinemia should be considered as atherosclerotic risk factor or it’s only marker of atherosclerosis. The elucidation of this problem could be of great practical importance and could allow to express adequate therapeutic recommendations. The manuscript contains the review of the most essential data concerning homocysteine biological properties, the reasons of hyperhomocysteinemia and results of studies focused on the relationship between hyperhomocysteinemia and atherosclerosis in type 2 diabetic patients.

Abstract

Hyperhomocysteinemia is a pathological phenomenon markedly associated with atherosclerosis and atherosclerosis-related diseases development. Patients with diabetes type 2 are especially affected by hiperhomocysteinemia. However, there is quite a lot of doubts if hiperhomocysteinemia should be considered as atherosclerotic risk factor or it’s only marker of atherosclerosis. The elucidation of this problem could be of great practical importance and could allow to express adequate therapeutic recommendations. The manuscript contains the review of the most essential data concerning homocysteine biological properties, the reasons of hyperhomocysteinemia and results of studies focused on the relationship between hyperhomocysteinemia and atherosclerosis in type 2 diabetic patients.
Get Citation

Keywords

hyperhomocysteinemia; type 2 diabetes; atherosclerosis

About this article
Title

Hyperhomocysteinemia in type 2 diabetic patients - still is considered as a risk factor or it’s only marker of atherosclerosis?

Journal

Clinical Diabetology

Issue

Vol 9, No 3-4 (2008): Practical Diabetology

Pages

182-186

Published online

2008-07-04

Bibliographic record

Diabetologia Praktyczna 2008;9(3-4):182-186.

Keywords

hyperhomocysteinemia
type 2 diabetes
atherosclerosis

Authors

Magdalena Borowska
Agata Adamczuk
Hanna Winiarska
Marzena Dworacka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl